Why has LGC's oligonucleotide synthesis service experienced a 20% decline in order volume from pharmaceutical clients this quarter?

Introduction

LGC's oligonucleotide synthesis service has experienced a 20% decline in order volume from pharmaceutical clients this quarter. This significant drop warrants a thorough investigation to identify the root cause and develop effective solutions. I'll approach this analysis systematically, examining both internal and external factors that could be contributing to the decline.

Step 1

Clarifying Questions (3 minutes)

• Considering the specificity of the decline, I'm wondering about the overall market trends. Has the total market for oligonucleotide synthesis changed recently?

Why it matters: This helps distinguish between a company-specific issue and an industry-wide trend. Expected answer: The market has remained stable or grown slightly. Impact on approach: If the market is growing, we'll focus more on internal factors and competitive positioning.

• Given the 20% decline, I'm curious about the timing. Did this drop occur suddenly or gradually over the quarter?

Why it matters: The pattern of decline can indicate whether it's due to a specific event or a gradual shift in client behavior. Expected answer: The decline was relatively sudden, starting about a month into the quarter. Impact on approach: A sudden drop would lead us to investigate recent changes or events more closely.

• Thinking about client segments, I'm wondering if this decline is uniform across all pharmaceutical clients or concentrated in specific segments?

Why it matters: This helps identify if the issue is widespread or limited to certain client types. Expected answer: The decline is more pronounced among mid-sized pharmaceutical companies. Impact on approach: We'd focus on understanding the specific needs and challenges of mid-sized pharma clients.

• Considering potential internal changes, have there been any significant modifications to the oligonucleotide synthesis service or pricing structure this quarter?

Why it matters: Internal changes could directly impact client orders and satisfaction. Expected answer: A new high-throughput synthesis option was introduced, but pricing remained stable. Impact on approach: We'd investigate how the new option was communicated and received by clients.